Adicet Bio, Inc. Increase (Decrease) in Other Noncurrent Assets
Adicet Bio, Inc. (ACET) reported Increase (Decrease) in Other Noncurrent Assets of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $5.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$3.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$4.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$116.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$308.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$353.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$358.00K.
- Adicet Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$929.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.00K 10-Q · filed 2026-08-05 | -$2.00K derived: sum of 3 quarters · filed 2026-08-05 | -$118.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$3.00K 10-Q · filed 2026-05-13 | -$7.00K derived: sum of 2 quarters · filed 2026-05-13 | -$123.00K derived: sum of 3 quarters · filed 2026-05-13 | -$211.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$120.00K derived: sum of 2 quarters · filed 2026-03-12 | -$208.00K derived: sum of 3 quarters · filed 2026-08-05 | -$308.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$204.00K derived: sum of 2 quarters · filed 2026-08-05 | -$304.00K 10-Q · filed 2025-11-05 | -$380.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$188.00K 10-Q · filed 2026-08-05 | -$264.00K derived: sum of 3 quarters · filed 2026-08-05 | -$351.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-13 | -$176.00K derived: sum of 2 quarters · filed 2026-05-13 | -$263.00K derived: sum of 3 quarters · filed 2026-05-13 | -$361.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$163.00K derived: sum of 2 quarters · filed 2026-03-12 | -$261.00K derived: sum of 3 quarters · filed 2026-03-12 | -$353.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$185.00K derived: sum of 2 quarters · filed 2025-11-05 | -$277.00K 10-Q · filed 2025-11-05 | -$370.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$190.00K 10-Q · filed 2025-08-07 | -$283.00K derived: sum of 3 quarters · filed 2025-08-07 | -$371.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$92.00K 10-Q · filed 2025-05-06 | -$185.00K derived: sum of 2 quarters · filed 2025-05-06 | -$273.00K derived: sum of 3 quarters · filed 2025-05-06 | -$366.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$181.00K derived: sum of 2 quarters · filed 2025-03-06 | -$274.00K derived: sum of 3 quarters · filed 2025-03-06 | -$358.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$181.00K derived: sum of 2 quarters · filed 2024-11-06 | -$265.00K 10-Q · filed 2024-11-06 | -$261.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$177.00K 10-Q · filed 2024-08-13 | -$173.00K derived: sum of 3 quarters · filed 2024-08-13 | -$698.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$84.00K 10-Q · filed 2024-05-14 | -$80.00K derived: sum of 2 quarters · filed 2024-05-14 | -$605.00K derived: sum of 3 quarters · filed 2024-05-14 | -$896.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$521.00K derived: sum of 2 quarters · filed 2024-03-19 | -$812.00K derived: sum of 3 quarters · filed 2024-03-19 | -$929.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | -$525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$816.00K derived: sum of 2 quarters · filed 2023-11-08 | -$933.00K 10-Q · filed 2023-11-08 | -$1.06M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$408.00K 10-Q · filed 2023-08-09 | -$531.00K derived: sum of 3 quarters · filed 2023-08-09 | -$566.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$117.00K 10-Q · filed 2023-05-09 | -$240.00K derived: sum of 2 quarters · filed 2023-05-09 | -$275.00K derived: sum of 3 quarters · filed 2023-05-09 | -$536.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$158.00K derived: sum of 2 quarters · filed 2023-03-15 | -$419.00K derived: sum of 3 quarters · filed 2023-03-15 | -$42.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$296.00K derived: sum of 2 quarters · filed 2022-11-08 | $81.00K 10-Q · filed 2022-11-08 | -$219.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $116.00K 10-Q · filed 2022-08-10 | -$184.00K derived: sum of 3 quarters · filed 2022-08-10 | $628.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $377.00K 10-Q · filed 2022-05-12 | $77.00K derived: sum of 2 quarters · filed 2022-05-12 | $889.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.43M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $512.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.05M derived: sum of 3 quarters · filed 2022-03-15 | $1.26M 10-K · filed 2022-03-15 |
| 2020-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.35M derived: sum of 2 quarters · filed 2021-11-10 | $1.56M 10-Q · filed 2021-11-10 | $1.67M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $543.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $748.00K 10-Q · filed 2021-08-12 | $855.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $205.00K 10-Q · filed 2021-05-17 | $312.00K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $88.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$19.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $302.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |